GPCR Q3 2025 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$74M

Net Income

-$66M

EPS (Diluted)

$-1.11

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$53M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$832M

Total Liabilities

$62M

Stockholders' Equity

$770M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$74M	-$46M	-61.0%
Net Income	-$66M	-$34M	-93.4%